The critical interplay between estrogen signaling and AD strongly matches with emerging data on estrogen receptor genes, cognitive decline, and AD dementia in postmenopausal women, giving a compelling narrative for the potential of estrogen as a neuroprotective agent [25]. Here, ESR1 is linked to Alzheimer disease.